id: androgenetic_alopecia_to_covid19_severity
name: Androgenetic Alopecia (AGA) → COVID-19 Severity and Mortality
from_node:
  node_id: androgenetic_alopecia
  node_name: Androgenetic Alopecia (AGA)
to_node:
  node_id: covid19_severity
  node_name: COVID-19 Severity and Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Androgenetic alopecia is correlated with hyperandrogenic state'
- 'Step 2: Elevated androgens may increase TMPRSS2 expression and activity'
- 'Step 3: TMPRSS2 facilitates SARS-CoV-2 viral entry and replication'
- 'Step 4: Enhanced viral entry and replication increases COVID-19 severity'
evidence:
  quality_rating: C
  n_studies: 2
  primary_citation: 'H. Moravvej et al. 2021. "Androgenetic alopecia and COVID‐19:
    A review of the hypothetical role of androgens." *Dermatologic Therapy*. https://doi.org/10.1111/dth.15004'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.074521'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: male_sex
  direction: strengthens
  strength: strong
  description: AGA is more prevalent in males and may compound gender-related COVID-19
    severity disparities
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/androgenetic_alopecia_to_covid19_severity.yaml
_category: biological
